MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB Epidemic

MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB Epidemic

Bacille Calmette-Guérin (BCG) is a live-attenuated strain of Mycobacterium bovis developed a century ago by repeated subculture. It remains the only vaccine against tuberculosis (TB) in use today, and it offers variable protection against the respiratory forms of TB responsible for transmission. The...

Full description

Bibliographic Details
Main Authors: Jesus Gonzalo-Asensio, Dessislava Marinova, Carlos Martin, Nacho Aguilo
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-12-01
Series:Frontiers in Immunology
Subjects:
tuberculosis
Bacille Calmette-Guérin
live vaccines
ESAT6
CFP10
MTBVAC
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2017.01803/full

Internet

http://journal.frontiersin.org/article/10.3389/fimmu.2017.01803/full

Similar Items